Membrane Separation Systems Market Size is Expected to Reach USD 72.8 billion, Advancing at a CAGR of 7.5% by 2034: Transparency Market Research Inc.
September 19, 2024 07:05 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc. -, Sept. 19, 2024 (GLOBE NEWSWIRE) -- The global membrane separation systems market (막 분리 시스템 시장) is estimated to flourish at a...
ABR INVESTOR UPDATE: Suffer Losses on Your Arbor Realty Trust, Inc. Investment? Contact BFA Law by September 30 about Pending Class Action Lawsuit (NYSE:ABR)
September 19, 2024 07:05 ET
|
Bleichmar Fonti & Auld
Arbor Realty Trust, Inc. investors that lost money on their investment are encouraged to contact BFA Law before September 30, 2024 legal deadline.
Incident IQ Announces New Leadership Appointments to Accelerate Growth and Customer Success
September 19, 2024 07:02 ET
|
Incident IQ
Atlanta, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Incident IQ, the workflow management platform built exclusively for K-12, today announced three important additions to its leadership team. Tiffany Mills...
Lifecore Biomedical Announces High-Speed, Multi-Purpose 5-Head Isolator Filler is GMP-Ready and Operational
September 19, 2024 07:00 ET
|
Lifecore Biomedical, Inc.
Installation and Qualification Successfully Completed for Closed-System Filler for Pre-Filled Syringes, Vials, and Cartridges Offers State-of-the-Art Speed and Aseptic Isolation Required for...
Arqit Quantum Inc. Announces 25:1 Reverse Share Split
September 19, 2024 07:00 ET
|
Arqit
LONDON, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Arqit Quantum Inc. (Nasdaq: ARQQ) (“Arqit” or the “Company”), a leader in quantum safe encryption, today announces that, following approval by the...
Autolus Therapeutics announces appointment of Matthias Will, M.D. as Chief Development Officer
September 19, 2024 07:00 ET
|
Autolus Therapeutics plc
Autolus Therapeutics announces appointment of Matthias Will, M.D. as Chief Development Officer
Vivos Therapeutics Announces Pricing of $4.3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
September 19, 2024 07:00 ET
|
Vivos Therapeutics, Inc
LITTLETON, Colo., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the...
OTC Markets Group Welcomes Slam Corp. to OTCQX
September 19, 2024 07:00 ET
|
OTC Markets
NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Slam Corp....
Larimar Therapeutics Announces Three Poster Presentations at the Upcoming International Congress for Ataxia Research
September 19, 2024 07:00 ET
|
Larimar Therapeutics
BALA CYNWYD, Pa., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare...
FactSet Reports Results for Fourth Quarter 2024
September 19, 2024 07:00 ET
|
FactSet Research Systems Inc.
Q4 GAAP revenues of $562.2 million, up 4.9% from Q4 2023.Organic Q4 ASV plus professional services of $2,272.8 million, up 4.8% year over year.Q4 GAAP operating margin of 22.7%, up approximately 110...